Research map: An interferon-gamma release assay for monitoring of T-cell responses to Epstein-Barr virus: Application to multiple sclerosis

Back to the article

Papers in this map

  1. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition · Clare Walton · 2020 · 2675 citations · Cited by this paper
  2. Head-to-head comparison of the performance of BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV and Cobas® SARS-CoV-2 & Influenza A/B assay for detection of respiratory viruses · 2025 · Related
  3. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis · Kjetil Bjørnevik · 2022 · 2083 citations · Cited by this paper
  4. Enhanced HBcAg immunoassay enables detection of clinically relevant low-level HBV viremia for treatment eligibility · 2026 · Related
  5. Epstein–Barr Virus Infection · Jeffrey I. Cohen · 2000 · 1650 citations · Cited by this paper
  6. Retrospective serology reveals chikungunya exposure among hospitalized dengue suspected cases in Minas Gerais, Brazil, 2024 · 2026 · Related
  7. Hepatitis B Virus Immunopathogenesis · Francis V. Chisari · 1995 · 1595 citations · Cited by this paper
  8. A series of diagnostic contamination events from seasonal influenza vaccines · 2026 · Related
  9. Treatment of Multiple Sclerosis: A Review · Stephen L. Hauser · 2020 · 987 citations · Cited by this paper
  10. 2025 JCV reviewer recognition list and best reviewer awards · 2025 · Related
  11. Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus · Andrew D. Hislop · 2007 · 774 citations · Cited by this paper
  12. Donor anti-cytomegalovirus IgG titer and risk of cytomegalovirus infection after D+R- kidney transplantation, results from the TransplantLines Biobank and Cohort Study · 2026 · Related
  13. Epstein–Barr Virus and Cancer · Paul J. Farrell · 2018 · 579 citations · Cited by this paper
  14. Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing · 2026 · Related
  15. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy · Sokratis A. Apostolidis · 2021 · 547 citations · Cited by this paper
  16. Performance comparison of the LIAISON Murex Anti-HEV IgG/IgM and the Elecsys Anti-HEV IgG/IgM assays for the detection of hepatitis E virus infection · 2026 · Related
  17. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. · Ruth J. Murray · 1992 · 510 citations · Cited by this paper
  18. Early viral load outperforms cytokines and lymphocytes in predicting SFTS prognosis: A dynamic immune profiling study · 2026 · Related
  19. T cell responses to cytomegalovirus · Paul Klenerman · 2016 · 494 citations · Cited by this paper
  20. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study · David Hillus · 2021 · 357 citations · Cited by this paper
  21. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2 · Jan D. Lünemann · 2008 · 336 citations · Cited by this paper
  22. Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients · Arumugam Palanichamy · 2014 · 293 citations · Cited by this paper
  23. Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing · NEIL W. BLAKE · 1997 · 261 citations · Cited by this paper
  24. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis · Jan D. Lünemann · 2006 · 236 citations · Cited by this paper
  25. Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases · Rajiv Khanna · 2000 · 209 citations · Cited by this paper
  26. Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease · Pauline Meij · 2003 · 142 citations · Cited by this paper
  27. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis · Giovanni Sotgiu · 2019 · 116 citations · Cited by this paper
  28. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis · Michael P. Pender · 2008 · 97 citations · Cited by this paper
  29. Management of Epstein-Barr Virus (EBV) Reactivation after Allogeneic Stem Cell Transplantation by Simultaneous Analysis of EBV DNA Load and EBV-Specific T Cell Reconstitution · Nicola E. Annels · 2006 · 70 citations · Cited by this paper
  30. The human T cell immune response to Epstein-Barr virus · Elise Landais · 2005 · 51 citations · Cited by this paper
  31. Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern · Massimo De Paschale · 2008 · 49 citations · Cited by this paper
  32. B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner · Theresa Graalmann · 2021 · 44 citations · Cited by this paper
  33. A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort · Pablo Barreiro · 2022 · 41 citations · Cited by this paper
  34. Detection of E pstein– B arr virus‐specific memory CD 4+ T cells using a peptide‐based cultured enzyme‐linked immunospot assay · Sandra A. Calarota · 2013 · 37 citations · Cited by this paper
  35. Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation · Tilman Schneider‐Hohendorf · 2024 · 37 citations · Cited by this paper
  36. Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination · Marta Fernández‐González · 2021 · 35 citations · Cited by this paper
  37. A Positive Correlation between the Precursor Frequency of Cytotoxic Lymphocytes to Autologous Epstein‐Barr Virus‐Transformed B Cells and Antibody Titer Level against Epstein‐Barr Virus‐Associated Nuclear Antigen in Healthy Seropositive Individuals · Yoichiro Kusunoki · 1993 · 29 citations · Cited by this paper
  38. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study · Yuzhen Xu · 2022 · 24 citations · Cited by this paper
  39. Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study · Lu M. Yang · 2022 · 24 citations · Cited by this paper

Source: OpenAlex (CC0)